KatRisk's Acquisition of RED: Revolutionizing Catastrophe Modeling in Insurance and Finance KatRisk has announced its acquisition of RED, enhancing its catastrophe modeling capabilities with focus on earthquake and other natural disasters for global clients.

KatRisk's Acquisition of RED: Revolutionizing Catastrophe Modeling in Insurance and Finance #USA #La_Jolla #RED #KatRisk #catastrophe_modeling

Exciting New Dining Experience: JOEY Restaurant Opens in San Diego's Westfield UTC San Diego welcomes its first JOEY Restaurant, a blend of global cuisines and vibrant atmosphere at Westfield UTC, opening April 23, 2026.

Exciting New Dining Experience: JOEY Restaurant Opens in San Diego's Westfield UTC #United_States #San_Diego #La_Jolla #JOEY_Restaurants #Westfield_UTC

CalciMedica's 2025 Financial Results and Promising Clinical Updates on Novel Therapies CalciMedica Inc. has reported its financial results for 2025 while providing significant updates on its clinical trials, including promising therapies for acute kidney injury and pancreatitis.

CalciMedica's 2025 Financial Results and Promising Clinical Updates on Novel Therapies #USA #La_Jolla #CalciMedica #Auxora #CM5480

Mysterious UFO hotspots uncovered around underwater canyons New research analyzed more than 80,000 UFO reports and found that there are 'clusters' of reports of sightings near submarine canyons in the continental US.

An analysis of about 80,000 public UFO reports found that West Coast sightings cluster near deep submarine canyons—La Jolla, Mugu Canyon, and Monterey Canyon—after comparing Nat… #aliens #california #dailymail #la_jolla #monterey #monterey_canyon #mugu_canyon #ovni #san_diego #uap #ufo #ufosky #usa

Myosin Therapeutics to Present Innovations at Biocom California's Investor Conference Myosin Therapeutics will showcase its oncology advancements at the Biocom California Global Partnering & Investor Conference, highlighting MT-125 and future strategies.

Myosin Therapeutics to Present Innovations at Biocom California's Investor Conference #United_States #oncology #La_Jolla #Myosin_Therapeutics #MT-125

CalciMedica Halts KOURAGE Clinical Trial Amid Safety Concerns CalciMedica Inc. has announced the discontinuation of its Phase 2 KOURAGE trial evaluating Auxora™ in AKI patients due to safety concerns highlighted by the Independent Data Monitoring Committee.

CalciMedica Halts KOURAGE Clinical Trial Amid Safety Concerns #United_States #La_Jolla #CalciMedica #Auxora #KOURAGE

#bluemonday #art #glass #aquarium #la_jolla #photography

Tony Callini Joins Technosylva as CFO to Drive Sustainable Growth Strategies Tony Callini has been appointed Chief Financial Officer at Technosylva, aiming to bolster sustainable growth and financial strategy in wildfire technology.

Tony Callini Joins Technosylva as CFO to Drive Sustainable Growth Strategies #United_States #La_Jolla #Technosylva #wildfire_science #Tony_Callini

KatRisk Acquires Symfos to Enhance Catastrophe Risk Management Platforms KatRisk strengthens its position in catastrophe risk intelligence by acquiring Symfos, enhancing underwriting capabilities and decision-making in insurance.

KatRisk Acquires Symfos to Enhance Catastrophe Risk Management Platforms #USA #La_Jolla #KatRisk #Symfos #Orchestra

Introducing Kat Izzo: A New Face in Aesthetic Wellness at ALCHEMĒ La Jolla ALCHEMĒ in La Jolla proudly announces that Kat Izzo, FNP-C, known from ABC's Bachelor franchise, joins their team to enhance wellness services.

Introducing Kat Izzo: A New Face in Aesthetic Wellness at ALCHEMĒ La Jolla #USA #La_Jolla #ALCHEMĒ #Kat_Izzo

Cybereason Unveils Cutting-Edge Vulnerability Management Tool for Proactive Cybersecurity Cybereason introduces an innovative Vulnerability Management product that enhances cybersecurity by transitioning from reactive defense to proactive mitigation, optimizing risk management for organizations.

Cybereason Unveils Cutting-Edge Vulnerability Management Tool for Proactive Cybersecurity #United_States #Cybersecurity #La_Jolla #Vulnerability_Management #Cybereason

CalciMedica Reveals Promising Data on CRAC Channel Inhibitor for Pulmonary Arterial Hypertension CalciMedica has announced exciting new preclinical findings regarding CM5480, a CRAC channel inhibitor, as a potential breakthrough treatment for pulmonary arterial hypertension.

CalciMedica Reveals Promising Data on CRAC Channel Inhibitor for Pulmonary Arterial Hypertension #USA #La_Jolla #CalciMedica #CRAC_channel #CM5480

CalciMedica Reveals Q3 2025 Financial Performance and Promising Clinical Progress CalciMedica reports financial results for Q3 2025 alongside crucial updates on its clinical trials and development projects, indicating positive progress.

CalciMedica Reveals Q3 2025 Financial Performance and Promising Clinical Progress #United_States #La_Jolla #CalciMedica #Auxora #AKI

CalciMedica's Auxora™ Shows Promising Results for AKI Treatment at ASN Kidney Week 2025 CalciMedica showcased significant advancements in the treatment of acute kidney injury (AKI) with Auxora™ at ASN Kidney Week 2025. Their findings highlight improvements in kidney function and inflammation reduction.

CalciMedica's Auxora™ Shows Promising Results for AKI Treatment at ASN Kidney Week 2025 #United_States #La_Jolla #CalciMedica #AKI #Auxora™

CalciMedica Partners with Telperian to Enhance Clinical Trials with AI Technology CalciMedica teams up with Telperian to leverage AI for analyzing clinical trial data, optimizing outcomes for AuxoraTM treatment.

CalciMedica Partners with Telperian to Enhance Clinical Trials with AI Technology #USA #La_Jolla #CalciMedica #Auxora #Telperian

Exploring Cybereason's 11 Essential Cybersecurity Controls for Enhanced Defense Strategies Cybereason unrolls its 11 Essential Cybersecurity Controls, crafted through extensive experience in incident response. These actionable controls are vital in fortifying organizations against cyber threats.

Exploring Cybereason's 11 Essential Cybersecurity Controls for Enhanced Defense Strategies #United_States #Cybersecurity #La_Jolla #Incident_Response #Cybereason

Advanced Lateral Flow Conference 2025: Explore Innovations and Key Insights The Advanced Lateral Flow Conference 2025 unveils its comprehensive agenda, highlighting key industry speakers and innovative sessions. Join leaders in rapid diagnostics.

Advanced Lateral Flow Conference 2025: Explore Innovations and Key Insights #United_States #diagnostics #La_Jolla #Lateral_Flow #ALFC_2025

La Jolla Cosmetic Medical Spa Opens New Location in Otay Ranch, California La Jolla Cosmetic Medical Spa expands with a new location in Otay Ranch, California, enhancing accessibility to their renowned aesthetic treatments.

La Jolla Cosmetic Medical Spa Opens New Location in Otay Ranch, California #United_States #La_Jolla #Chula_Vista #Cosmetic_Medical_Spa #Otay_Ranch

ALCHEMĒ Launches New Wellness Studio in La Jolla with Joyful Grand Opening Celebration ALCHEMĒ opens a new location in La Jolla, offering an evening of luxury wellness experiences. Join the community and explore vibrant living with innovative services.

ALCHEMĒ Launches New Wellness Studio in La Jolla with Joyful Grand Opening Celebration #United_States #La_Jolla #Wellness_Services #ALCHEMĒ

CaliBagels Inc. and Thomas'® Brand Launch New Bagel Chips Nationwide CaliBagels Inc. has teamed up with Thomas'® to introduce a range of Deli Style Bagel Chips, set to hit stores in 2026, bringing delicious flavors to snack lovers nationwide.

CaliBagels Inc. and Thomas'® Brand Launch New Bagel Chips Nationwide #USA #La_Jolla #CaliBagels #Thomas' #Bagel_Chips

Technosylva and AiDASH Join Forces Against Wildfire Risks through Tech Integration Discover how Technosylva and AiDASH are merging advanced technologies to significantly lower wildfire risks and improve utilities' response strategies in extreme weather conditions.

Technosylva and AiDASH Join Forces Against Wildfire Risks through Tech Integration #USA #La_Jolla #Technosylva #wildfire_management #AiDASH

CalciMedica Provides Financial and Clinical Updates for Q2 2025 CalciMedica Inc. reports Q2 2025 financial results, ongoing trials, and corporate developments, highlighting progress in treatments for acute kidney injury.

CalciMedica Provides Financial and Clinical Updates for Q2 2025 #United_States #La_Jolla #CalciMedica #Auxora #AKI

Cybereason Sets the Standard in Cybersecurity with Gartner Recognition in 2025 Market Guide Cybereason has been named a Representative Vendor in the 2025 Gartner Market Guide for digital forensics and incident response retainer services for the fourth consecutive year.

Cybereason Sets the Standard in Cybersecurity with Gartner Recognition in 2025 Market Guide #USA #Cybersecurity #Gartner #La_Jolla #Cybereason

Bob Rowe's Appointment to Technosylva Board Marks New Era in Wildfire Risk Management Strategies Technosylva announces Bob Rowe's appointment to its Board of Directors, enhancing its strategies for wildfire and extreme weather risk management.

Bob Rowe's Appointment to Technosylva Board Marks New Era in Wildfire Risk Management Strategies #USA #La_Jolla #Technosylva #Wildfire_Risk #Bob_Rowe

Palantir's Jeremy Elser to Discuss AI's Impact on Diagnostics at 2025 Advanced Lateral Flow Conference Join Jeremy Elser of Palantir as he keynotes the 2025 Advanced Lateral Flow Conference, exploring AI's transformative role in diagnostics and science operations.

Palantir's Jeremy Elser to Discuss AI's Impact on Diagnostics at 2025 Advanced Lateral Flow Conference #USA #La_Jolla #Palantir #Jeremy_Elser #AI_in_Diagnostics

CalciMedica Unveils Insights from KOURAGE Trial in American Journal of Nephrology CalciMedica Inc. announces a publication detailing the Phase 2 KOURAGE trial design for Auxora in treating AKI with respiratory failure, featured in the American Journal of Nephrology.

CalciMedica Unveils Insights from KOURAGE Trial in American Journal of Nephrology #USA #La_Jolla #CalciMedica #Auxora #KOURAGE_Trial

CalciMedica to Host Symposium on Novel Therapies for Acute Kidney Injury at Vicenza Course 2025 CalciMedica will present advancements in calcium release-activated therapies at an upcoming symposium during the 43rd Vicenza Course on Critical Care Nephrology in Italy.

CalciMedica to Host Symposium on Novel Therapies for Acute Kidney Injury at Vicenza Course 2025 #United_States #La_Jolla #CalciMedica #Auxora #CRAC

Nominations Now Open for the 2025 Advanced Lateral Flow Conference Awards The Advanced Lateral Flow Conference is welcoming nominations for its prestigious awards, recognizing innovation and achievements in diagnostics.

Nominations Now Open for the 2025 Advanced Lateral Flow Conference Awards #USA #La_Jolla #DCN_Dx #Lateral_Flow #ALFC_2025

CalciMedica Makes Significant Progress in Novel Biopharmaceutical Development Amid Q1 Financial Results CalciMedica Inc. reports encouraging developments for its biopharmaceutical pipeline and strong financial backing as of Q1 2025.

CalciMedica Makes Significant Progress in Novel Biopharmaceutical Development Amid Q1 Financial Results #United_States #La_Jolla #CalciMedica #Auxora #AKI

HOPE Therapeutics and NRx Pharmaceuticals Announce Major Step in Transforming Mental Health Care with Kadima Institute Acquisition The acquisition of Kadima Neuropsychiatry Institute marks a landmark development for HOPE Therapeutics aimed at revolutionizing mental health treatment through cutting-edge methodologies.

HOPE Therapeutics and NRx Pharmaceuticals Announce Major Step in Transforming Mental Health Care with Kadima Institute Acquisition #USA #NRx_Pharmaceuticals #La_Jolla #Hope_Therapeutics #Kadima_Institute